5-ethyl-10-fluoro-5-hydroxy-(5R)-4,5,13,15-tetrahydro-1H,3H-oxepino[3',4':6,7]indolizino[1,2-b]quinoline-3,15-dione

ID: ALA306796

Chembl Id: CHEMBL306796

PubChem CID: 11794148

Max Phase: Preclinical

Molecular Formula: C21H17FN2O4

Molecular Weight: 380.38

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC[C@@]1(O)CC(=O)OCc2c1cc1n(c2=O)Cc2cc3cc(F)ccc3nc2-1

Standard InChI:  InChI=1S/C21H17FN2O4/c1-2-21(27)8-18(25)28-10-14-15(21)7-17-19-12(9-24(17)20(14)26)5-11-6-13(22)3-4-16(11)23-19/h3-7,27H,2,8-10H2,1H3/t21-/m1/s1

Standard InChI Key:  VJSCOIPYUQHYDB-OAQYLSRUSA-N

Associated Targets(Human)

TOP1 Tclin DNA topoisomerase I (7553 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
T-24 (2342 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 380.38Molecular Weight (Monoisotopic): 380.1172AlogP: 2.61#Rotatable Bonds: 1
Polar Surface Area: 81.42Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 13.81CX Basic pKa: 2.19CX LogP: 1.30CX LogD: 1.30
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.51Np Likeness Score: 0.54

References

1. Lavergne O, Demarquay D, Bailly C, Lanco C, Rolland A, Huchet M, Coulomb H, Muller N, Baroggi N, Camara J, Le Breton C, Manginot E, Cazaux JB, Bigg DC..  (2000)  Topoisomerase I-mediated antiproliferative activity of enantiomerically pure fluorinated homocamptothecins.,  43  (11): [PMID:10841808] [10.1021/jm000129j]
2. Huang Q, Wang L, Lu W..  (2013)  Evolution in medicinal chemistry of E-ring-modified Camptothecin analogs as anticancer agents.,  63  [PMID:23578545] [10.1016/j.ejmech.2013.01.058]

Source